Contact this trialFirst, we need to learn more about you.
Atypical Antipsychotic
ALKS 3831 for Bipolar Disorder
Recruiting2 awardsPhase 3
Atlanta, Georgia
This trial will study the safety and effectiveness of ALKS 3831 in people with schizophrenia, schizophreniform disorder, or bipolar I disorder.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.